Deficiencies in PRLR signaling due to PRLR activity alterations or wrong intracellular pathway connectivity, crosstalk, or co-regulation exerted by other factors, such as hypothalamic or paracrine mechanisms, can lead to pituitary hyperplasia and eventual tumor development. Here, PRLR is linked to neoplasm.